The corresponding author takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest statements, are properly completed. The corresponding author should respond to editorial queries throughout the submission and peer review process in a timely manner and should cooperate with any requests from the journal after publication. The Iran Nanotechnology Innovation Council publishing house may not allow adding authors or changing the first or the corresponding authors after the final acceptance of the article. If any author wishes to be removed from the byline, he or she should submit a letter signed by the author, as well as all other authors, indicating his or her wish to be deleted from the list of authors. Any change in the name order in the byline requires a letter signed by all authors indicating agreement with the same. Conflict of Interest
Authors are required to disclose all relationships or interests in relation to their work. All submitted manuscripts must include a ‘Conflict of Interest’ section at the end of the manuscript listing all financial and non-financial conflict of interests. Where authors have no conflict of interests, the statement should read “The authors declare that they have no conflict of interest.” A competing interest exists when the authors’ interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations.
Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article. Financial competing interests include (but are not limited to):
Research grants from funding agencies (The research funder and the grant number are required)
Financial support for educational programs.
Employment or consultation.
Position on advisory board or board of directors or other type of management relationships.
Financial relationships, for example Receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
Intellectual property rights (e.g., patents, copyrights and royalties from such rights).
Holdings of spouse and/or children that may have financial interest in the work.
In addition, non-financial interests that may be important to readers should be disclosed. These may include but are not limited to political, personal, religious, ideological, academic, and intellectual competing interests. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Human and Animal Rights
Research involving human subjects, human material, or human data, should include a statement that the studies performed in accordance with the Declaration of Helsinki and approved by an appropriate ethics committee. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.
Also, the welfare of animals used for research must be respected. When reporting experiments on animals, authors should indicate whether the international, national, and/or institutional guidelines for the care and use of animals have been followed, and that the studies have been approved by a research ethics committee at the institution or practice at which the studies were conducted (where such a committee exists). For all those experimental studies done through animals, the European Committee Guidelines on the protection of animals used for scientific purposes should be strictly observed, addressed & stated.
All clinical trials should be registered before they are going to be started in clinical trials registries & bear a clinical trial registration number and name of the trial. The authors may use International Clinical Trials Registry Platform (ICTRP) of WHO or its sister registries like Iranian Registry of Clinical Trials. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT statement. No clinical trial paper will be accepted for review & publishing without a valid clinical trials registration number.
Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information. Informed Consent
For all research involving human subjects, informed consent to participate in the study should be obtained from participants. For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants. A statement to this effect should appear in the manuscript. Identifying details (names, dates of birth, identity numbers and other information) of the participants that were studied should not be published in written descriptions, photographs, and genetic profiles unless the information is essential for scientific purposes and the participant (or parent or guardian if the participant is incapable) gave written informed consent for publication. The final decision on whether consent to publish is required lies with the Editor.
Publication Ethics Considerations
All Iran Nanotechnology Innovation Council publishing house journals are committed to follow and apply “International Standards for Authors” of Committee on Publication Ethics in designing and leading the Journal’s reviewing and publishing process and dealing with their issues. You may find the International Standards for Authors, here. Authors should read the standard and apply it to their works, completely.
Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
Drafting the work or revising it critically for important intellectual content; AND
Final approval of the version to be published; AND
Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
It is a requirement that all authors have been accredited as appropriate upon submission of the manuscript. Contributors who do not qualify as authors should be mentioned under Acknowledgements.
In addition, authors are advised to follow the following code of ethics strictly submit manuscripts, which are their originals works or of the work, they are associated with during their tenure.
Submitted manuscripts should contain original and new results, data, and their ideas, which are not submitted for publishing to other publications or published elsewhere. Fabrication of data and results, intellectual property theft and plagiarism are highly unacceptable, it is beyond the ethics of an author. Information obtained via various media should be provided in the manuscript only with prior permission from the owner of the source of information or data.
They should properly cite the work they are referring to; authors are advised to crosscheck the reference before submission of manuscript.
They may not promote in any form via any media to get their works published. No article should have an author who is not directly involved in the work for any means or reasons.
Authors and co-authors are requested to review and ensure the accuracy and validity of all the results prior to submission. Any potential conflict of interest should be informed to the editor in advance. Authors are bound by the Creative Commons licensing policy of publication.
All authors are requested to submit the copyright transfer form without failure once they receive the acceptance of their article for publication. Editors
All Iran Nanotechnology Innovation Council publishing house journals are committed to follow and apply “International Standards for Editors” of Committee on Publication Ethics in designing and leading the Journal’s reviewing and publishing process and dealing with their issues. You may find the International Standards for Editors, here.
The term editor is a common terminology used to refer Chief Editor of any journal, Content editor, and Subject Editor and Editorial board members.
Editors of Journal are insisted to have full responsibility for editorial and technical decisions of the journal. Any editor or office bearer should not intervene or give comment on any editorial decisions taken on any manuscript by the concerned editor. Editors are requested to give unbiased considerations for the articles submitted. The Journal aims for rapid publication, editors are advised to process the manuscripts promptly and diligently.
Editors are the sole responsible persons for the acceptance or rejection of a manuscript, it may be subjected to peer review, but the final decision is bound to the concerned editor.
Any decision taken or matter of concern about a submitted article should not be revealed to anyone by an editor. If one of the editors is willing to publish an article the article should be processed by another editor.
Editor should refrain from using the information, data, theories, or interpretations of any submitted manuscript in her/his own work until that manuscript is in press.
Reviewers
Reviewers are the main members contributing to the benefit of the journal being a peer reviewed (blind referee) journal they are insisted not to disclose their identity in any form.
A reviewer should immediately decline to review an article submitted if he/she feels that the article is technically unqualified or if the timely review cannot be done by him/her or if the article has a conflict of interest.
All submissions should be treated as confidential, editorial approval might be given for any outside person’s advice received.
No reviewer should pass on the article submitted to him/her for review to another reviewer in his own concern, it should be declined immediately.
Reviewers, being the base of the whole quality process, should ensure that the articles published should be of high quality and original work. He may inform the editor if he finds the article submitted to him for review is under consideration in any other publication to his/her knowledge.
There are no hard and fast rules to analysis an article, this can be done on case-to-case basis considering the worthiness, quality, and originality of the article submitted.
In general, cases the following may be checked in a review:
Structure of the article submitted and its relevance to author guidelines.
Purpose and Objective of the article
Method of using transitions in the article
Introduction given and the conclusion/ suggestions provided.
References provided to substantiate the content.
Grammar, punctuation, and spelling
Plagiarism issues
Suitability of the article to the need
A reviewer’s comment decides the acceptance or rejection of an article and they are one major element in a peer review process. All our reviewers are requested to go through the articles submitted to them for review in detail and give the review comments without any bias, which will increase the quality of our journals.
Breach of Code
Being an association dedicated to the researcher fraternity, we all should ensure that the code of ethics formed is followed in all possible ways. Being a not-for-profit body, it is the internal responsibility of a person who should have to follow the codes, there is no enforcement to follow.
All Journal committee members are entitled to take action against an individual if they are found to be violating the code. Clinical Trial Registry
All clinical trials should be registered earlier in one of the worldwide clinical trial registries like: http://irct.ir/. The clinical trial code should be provided at the time of submission.
Chief Editors is accountable for everything published in the journal. This means the editors.
1.1 strive to meet the needs of readers and authors. 1.2 strive to constantly improve their journal. 1.3 have processes in place to assure the quality of the material they publish. 1.4 champion freedom of expression. 1.5 maintain the integrity of the academic record. 1.6 precludes business needs from compromising intellectual and ethical standards. 1.7 always be willing to publish corrections, clarifications, retractions, and apologies when needed.
Best Practice for Editors would include:
actively seeking the views of authors, readers, reviewers, and editorial board members about ways of improving their journal’s processes
encouraging and being aware of research into peer review and publishing and reassessing their journal’s processes in the light of new findings
supporting initiatives designed to reduce research and publication misconduct.
supporting initiatives to educate researchers about publication ethics.
assessing the effects of their journal policies on author and reviewer behavior and revising policies, as required, to encourage responsible behavior and discourage misconduct.
ensuring that any press releases issued by their journal reflect the message of the reported article and put it into context.
2. Readers
2.1 Readers should be informed about who has funded research or other scholarly work and whether the funders had any role in the research and its publication and, if so, what this was.
Best practice for editors would include:
ensuring that all published reports and reviews of research have been reviewed by suitably qualified reviewers including statistical review.
ensuring that non-peer-reviewed sections of their journal are clearly identified.
adopting processes that encourage accuracy, completeness and clarity of research reporting including technical editing and the use of appropriate guidelines and checklists.
considering developing a transparency policy to encourage maximum disclosure about the provenance of non-research articles.
adopting authorship or contributor ship systems that promote good practice (i.e., so that listings accurately reflect who did the work) and discourage misconduct (e.g., ghost and guest authors)
informing readers about steps taken to ensure that submissions from members of the journal’s staffer editorial board receive an objective and unbiased evaluation.
3. Informing readers about steps taken to ensure that submissions from members of the journal’s staff or editorial board receive an objective and unbiased evaluation
4. Relations with authors
4.1 Editors’ decisions to accept or reject a paper for publication should be based on the paper’s importance, originality and clarity, and the study’s validity and its relevance to the remit of the journal.4.2 Editors should not reverse decisions to accept submissions unless serious problems are identified with the submission.
4.3 New editors should not overturn decisions to publish submissions made by the previous editor unless serious problems are identified.
4.4 A description of peer review processes should be published, and editors should be ready to justify any important deviation from the described processes.
4.5 Journals should have a declared mechanism for authors to appeal against editorial decisions.
4.6 Editors should publish guidance to authors on everything that is expected of them. This guidance should be regularly updated and should refer to or link to this code.
4.7 Editors should provide guidance about criteria for authorship and/or who should be listed as a contributor following the standards within the relevant field.
Best practice for editors would include:
reviewing author instructions regularly and providing links to relevant guidelines
publishing relevant competing interests for all contributors and publishing corrections if competing interests are revealed after publication.
ensuring that appropriate reviewers are selected for submissions (i.e., individuals who are able to judge the work and are free from disqualifying competing interests)
respecting requests from authors that an individual should not review their submission, if these are well-reasoned and practicable.
publishing details of how they handle cases of suspected misconduct.
publishing submission and acceptance dates for articles
5. Relations with reviewers
5.1 Editors should provide guidance to reviewers on everything that is expected of them including the need to handle submitted material in confidence. This guidance should be regularly updated and should refer to or link to this code.
5.2 Editors should require reviewers to disclose any potential competing interests before agreeing to review a submission.
5.3 Editors should have systems to ensure that peer reviewers’ identities are protected unless they use an open review system that is declared to authors and reviewers.
Best practice for editors would include:
encouraging reviewers to comment on ethical questions and possible research and publication misconduct raised by submissions (e.g., unethical research design, insufficient detail on patient consent or protection of research subjects (including animals), inappropriate data manipulation and presentation)
encouraging reviewers to comment on the originality of submissions and to be alert to redundant publication and plagiarism.
considering providing reviewers with tools to detect related publications (e.g., links to cited references and bibliographic searches)
sending reviewers’ comments to authors in their entirety unless they contain offensive or libelous remarks.
seeking to acknowledge the contribution of reviewers to the journal.
encouraging academic institutions to recognize peer review activities as part of the scholarly process.
monitoring the performance of peer reviewers and taking steps to ensure this is of a high standard.
developing and maintaining a database of suitable reviewers and updating this on the basis of reviewer performance
ceasing to use reviewers who consistently produce discourteous, poor quality or late reviews.
ensuring that the reviewer database reflects the community for their journal and adding new reviewers as needed.
using a wide range of sources (not just personal contacts) to identify potential new reviewers (e.g., author suggestions, bibliographic databases)
following the COPE flowchart in cases of suspected reviewer misconduct
6. Relations with editorial board members
6.1 Editors should provide new editorial board members with guidelines on everything that is expected of them and should keep existing members updated on new policies and developments.
Best practice for editors would include:
having policies in place for handling submissions from editorial board members to ensure unbiased review.
identifying suitably qualified editorial board members who can actively contribute to the development and good management of the journal.
regularly reviewing the composition of the editorial board
providing clear guidance to editorial board members about their expected functions and duties, which might include:
acting as ambassadors for the journal
supporting and promoting the journal
seeking out the best authors and best work (e.g., from meeting abstracts) and actively encouraging submissions
reviewing submissions to the journal
accepting commissions to write editorials, reviews and commentaries on papers in their specialist area.
attending and contributing to editorial board meetings
consulting editorial board members periodically (e.g., once a year) to gauge their opinions about the running of the journal, informing them of any changes to journal policies and identifying future challenges.
7. Relations with Publisher
7.1 The relationship of editors to Publisher and the owner is based firmly on the principle of editorial independence.
7.2 Editors should make decisions on which articles to publish based on quality and suitability for the journal and without interference from Publisher.
7.3 Editors have a written contract(s) setting out their relationship with Publisher.
7.4 The terms of this contract are in line with the COPE Code of Conduct for Journal Editors.
Best practice for editors would include:
communicating regularly with Publisher
8. Editorial and peer review processes
8.1 Editors should strive to ensure that peer review at their journal is fair, unbiased, and timely.
8.2 Editors should have systems to ensure that material submitted to their journal remains confidential while under review.
Best practice for editors would include:
ensuring that people involved with the editorial process (including themselves) receive adequate training and keep abreast of the latest guidelines, recommendations and evidence about peer review and journal management.
keeping informed about research into peer review and technological advances
adopting peer review methods best suited for their journal and the research community it serves
reviewing peer review practices periodically to see if improvement is possible.
referring troubling cases to COPE, especially when questions arise that are not addressed by the COPE flowcharts, or new types of publication misconduct are suspected.
considering the appointment of an ombudsperson to adjudicate in complaints that cannot be resolved internally.
9. Quality assurance
9.1 Editors should take all reasonable steps to ensure the quality of the material they publish, recognizing that journals and sections within journals will have different aims and standards.
Best practice for editors would include:
having systems in place to detect falsified data (e.g., inappropriately manipulated photographic images or plagiarized text) either for routine use or when suspicions are raised.
basing decisions about journal house style on relevant evidence of factors that raise the quality of reporting (e.g., adopting structured abstracts, applying guidance) rather than simply on aesthetic grounds or personal preference.
10. Protecting individual data
10.1 Editors must obey laws on confidentiality in their own jurisdiction. Regardless of local statutes, however, they should always protect the confidentiality of individual information obtained in the course of research or professional interactions. It is therefore almost always necessary to obtain written informed consent for publication from people who might recognize themselves or be identified by others (e.g., from case reports or photographs). It may be possible to publish individual information without explicit consent if public interest considerations outweigh possible harms, it is impossible to obtain consent and a reasonable individual would be unlikely to object to publication.
Best practice for editors would include:
publishing their policy on publishing individual data (e.g., identifiable personal details or images) and explaining this clearly to authors
Note that consent to take part in research or undergo treatment is not the same as consent to publish personal details, images or quotations.
11. Encouraging ethical research (e.g., research involving humans or animals)
11.1 Editors should endeavor to ensure that research they publish is carried out according to the relevant internationally Declaration of Helsinki for clinical research, and the AERA and BERA guidelines for educational research.
11.2 Editors should seek assurances that all research has been approved by an appropriate body (e.g., research ethics committee, institutional review board) where one exists. However, editors should recognize that such approval does not guarantee that the research is ethical.
Best practice for editors would include:
being prepared to request evidence of ethical research approval and to question authors about ethical aspects (such as how research participant consent was obtained or what methods were employed to minimize animal suffering) if concerns are raised or clarifications are needed.
ensuring that reports of clinical trials cite compliance with the Declaration of Helsinki, Good Clinical Practice.
appointing a journal ethics advisor or panel to advise on specific cases and review journal policies periodically.
12. Dealing with possible misconduct
12.1 Editors have a duty to act if they suspect misconduct or if an allegation of misconduct is brought to them. This duty extends to both published and unpublished papers.
12.2 Editors should not simply reject papers that raise concerns about possible misconduct. They are ethically obliged to pursue alleged cases.
12.3 Editors should follow the COPE flowcharts where applicable.
12.4 Editors should first seek a response from those suspected of misconduct. If they are not satisfied with the response, they should ask the relevant employers, or institution, or some appropriate body (perhaps a regulatory body or national research integrity organization) to investigate.
12.5 Editors should make all reasonable efforts to ensure that a proper investigation into alleged misconduct is conducted; if this does not happen, editors should make all reasonable attempts to persist in obtaining a resolution to the problem. This is an onerous but important duty.
13. Ensuring the integrity of the academic record
13.1 Errors, inaccurate or misleading statements must be corrected promptly and with due prominence.
13.2 Editors should follow the COPE guidelines on retractions.
Best practice for editors would include:
taking steps to reduce covert redundant publication (e.g., by requiring all clinical trials to be registered)
ensuring that published material is securely archived (e.g., via online permanent repositories, such as PubMed Central)
having systems in place to give authors the opportunity to make original research articles freely available.
14. Intellectual property
14.1 Editors should be alert to intellectual property issues and work with Publisher to handle potential breaches of intellectual property laws and conventions.
Best practice for editors would include:
adopting systems for detecting plagiarism (e.g., software, searching for similar titles) in submitted items (either routinely or when suspicions are raised)
supporting authors whose copyright has been breached or who have been the victims of plagiarism.
being prepared to work with Publisher to defend authors’ rights and pursue offenders (e.g., by requesting retractions or removal of material from websites) irrespective of whether their journal holds the copyright.
15. Encouraging debate
15.1 Editors should encourage and be willing to consider cogent criticisms of work published in their journal.
15.2 Authors of criticized material should be given the opportunity to respond.
15.3 Studies reporting negative results should not be excluded.
Best practice for editors would include:
being open to research that challenges previous work published in the journal.
16. Complaints
16.1 Editors should respond promptly to complaints and should ensure there is a way for dissatisfied complainants to take complaints further. This mechanism should be made clear in the journal and should include information on how to refer unresolved matters to COPE.
17.1 Journals should have policies and systems in place to ensure that commercial considerations do not affect editorial decisions (e.g., advertising departments should operate independently from editorial departments).
17.2 Editors should have declared policies on advertising in relation to the content of the journal and on processes for publishing sponsored supplements.
17.3 Reprints should be published as they appear in the journal unless a correction needs to be included in which case it should be clearly identified.
Best practice for editors would include:
publishing a general description of their journal’s income sources (e.g., the proportions received from display advertising, reprint sales, sponsored supplements, page charges, etc.)
ensuring that the peer review process for sponsored supplements is the same as that used for the main journal.
ensuring that items in sponsored supplements are accepted solely on the basis of academic merit and interest to readers and decisions about such supplements are not influenced by commercial considerations.
18. Conflicts of interest
18.1 Editors should use ICMJE form and procedure for managing conflicts of interest issues. 18.2 Journals should have a declared process for handling submissions from the editors, employees, or members of the editorial board to ensure unbiased review. Originality and Duplicate Publication
Manuscripts submitted to the journals must be original and not published or submitted for publication elsewhere. This rule also applies to manuscripts submitted elsewhere while the journal contribution is under evaluation. It is mandatory for all authors to resolve any copyright issues when citing a figure or table from a different journal. Research and Publication Misconduct
Iran Nanotechnology Innovation Council publishing house journals & their editorial board will incessantly work towards observing publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, ethical problem with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and etc. When the journal faces suspected cases of research and publication misconduct, the resolving process will be followed by guidelines provided by the "Committee on Publication Ethics (COPE)". The complete guidelines appear on COPE website: http://www.publicationethics.org. Plagiarism
We strongly recommend our authors to check their manuscript content before its submission to any of our journals for publication. The Authors may use trustable valid "Plagiarism Checking software’s" to make sure that their manuscripts are Plagiarism free. All TUMS journals will check Plagiarism for all the submitted manuscripts upon receiving and also before publishing through iThenticate & other Plagiarism Detection Software’s. If the plagiarism is observed either by reviewer, Editor-in-Chiefs, readers or editorial staffs at any stage of publication process, the manuscript will be rejected, and it would be notified to the corresponding author. Self-plagiarism is also considered & managed accordingly.
230
